| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.48▼ | 1.48▼ | 1.46▼ | 1.58▼ | 1.74▼ |
| MA10 | 1.47▼ | 1.45▲ | 1.42▲ | 1.68▼ | 1.54▼ |
| MA20 | 1.45▼ | 1.43▲ | 1.51▼ | 1.81▼ | 1.50▼ |
| MA50 | 1.39▲ | 1.58▼ | 1.66▼ | 1.46▼ | 1.30▲ |
| MA100 | 1.48▼ | 1.69▼ | 1.80▼ | 1.47▼ | 1.01▲ |
| MA200 | 1.61▼ | 1.83▼ | 1.68▼ | 1.40▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.020▲ | 0.010▲ | -0.069▼ | 0.003▲ |
| RSI | 51.046▲ | 46.082▼ | 41.166▼ | 36.353▼ | 49.797▼ |
| STOCH | 51.273 | 78.602 | 67.230 | 19.063▼ | 61.697 |
| WILL %R | -88.889▼ | -28.571 | -39.394 | -77.011▼ | -63.704 |
| CCI | -45.636 | 51.611 | 0.928 | -145.937▼ | 3.068 |
|
Friday, March 05, 2021 03:04 PM
Quantum Leap Healthcare Collaborative-sponsored I-SPY COVID Trial will not further test Aerpio Pharmaceuticals Inc's (NASDAQ: ARPO) razuprotafib. Razuprotafib was chosen because it was believed to ...
|
|
Friday, March 05, 2021 05:05 AM
Quantum Leap Healthcare Collaborative (QLHC), the sponsor of the I-SPY COVID Trial, will not proceed with further testing of the Aerpio Pharmaceuticals (Nasdaq: ARPO) drug, razuprotafib. Razuprotafib ...
|
|
Thursday, March 04, 2021 09:02 PM
Quantum Leap Healthcare Collaborative (QLHC), the sponsor of the I-SPY COVID Trial, will not proceed with further testing of the Aerpio Pharmaceuticals (Nasdaq: ARPO) drug, razuprotafib. Razuprotafib ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/03/21 | 1.46 | 1.53 | 1.45 | 1.45 | 449,687 |
| 05/03/21 | 1.48 | 1.51 | 1.25 | 1.47 | 3,834,572 |
| 04/03/21 | 1.68 | 1.685 | 1.4801 | 1.55 | 1,680,057 |
| 03/03/21 | 1.74 | 1.785 | 1.60 | 1.70 | 1,433,233 |
| 02/03/21 | 1.76 | 1.81 | 1.72 | 1.74 | 602,130 |
| 01/03/21 | 1.77 | 1.82 | 1.73 | 1.76 | 490,781 |
| 26/02/21 | 1.77 | 1.82 | 1.71 | 1.78 | 715,419 |
| 25/02/21 | 1.83 | 1.89 | 1.7341 | 1.77 | 1,683,305 |
| 24/02/21 | 1.81 | 1.92 | 1.805 | 1.82 | 818,252 |
| 23/02/21 | 1.90 | 1.91 | 1.71 | 1.78 | 2,724,646 |
|
|
||||
|
|
||||
|
|